Laboratorios Farmaceuticos Rovi SA
Suletud
SektorTervishoid
57.6 -1.03
Ülevaade
Aktsiahinna muutus
24h
Min
57.6
Max
58.4
Sissetulek | 80M 89M |
|---|---|
Müük | 39M 192M |
P/E Sektori keskmine | 16.085 57.002 |
Aktsiakasum | 1.466 |
Dividenditootlus | 1.63 |
Kasumimarginaal | 46.582 |
Töötajad | 2,470 |
EBITDA | 83M 101M |
Dividenditootlus Sektori keskmine | 1.63% 2.22% |
|---|---|
Järgmine tulemuste avaldamine | 5. nov 2026 |
Turukapital | 220M 3B |
|---|---|
Eelmine avamishind | 58.63 |
Eelmine sulgemishind | 57.6 |
Uudiste sentiment
By Acuity
50%
50%
152 / 340 Pingereas Healthcare
Laboratorios Farmaceuticos Rovi SA Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Laboratorios Farmaceuticos Rovi SA Prognoos
Sentiment
By Acuity
152 / 340 Pingereas Tervishoid
Uudiste sentiment
Neutral
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Alla keskmise
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Laboratorios Farmaceuticos Rovi SA
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.